Paediatric atopic dermatitis – Towards disease modification

Neurodermatitis,Chronic,Constitutional,Atopic,Eczema,Small,Newborn,Baby,With,Dry

Selecting therapies in severe paediatric atopic dermatitis in order to modify disease progression and achieve remission

Learning objectives

You will learn:

  • Why the burden of paediatric atopic dermatitis extends beyond visible skin disease
  • How skin barrier dysfunction and type 2 inflammation may contribute to allergic sensitisation and the atopic march
  • The difference between disease control, remission and disease modification
  • What the paediatric dupilumab studies show about sustained disease control and treatment free remission
  • What evidence currently supports early intervention as a potential disease-modifying strategy.

To access this module, please register or login: